| |
Demonstrate knowledge of the evolving roles of afferents and efferents in the pathophysiology of OAB, focusing on urgency as the core symptom |
| |
Examine the burden of urge incontinence episodes on patients with OAB, and explore theories behind the increased prevalence of incontinence in women and the aging population |
| |
Assess cutting-edge clinical data concerning the pharmacologic agents currently available for the treatment of OAB and apply this knowledge to patient cases |
| |
Evaluate the important role that dose titration can play for the individual OAB patient and employ a patient-centered treatment strategy that explores the benefits of dosing antimuscarinics to obtain a balance between efficacy and tolerability |
| |
Analyze patient-reported outcomes instruments and confidently use them to assess an OAB patient’s symptoms, symptom severity, health-related quality of life, and treatment satisfaction |
| |
Investigate the potential of alternative pharmacologic targets in OAB |